Under construction – not a live service
Sign in
Taking peopleNo phase

Validating Two New Rating Scales for Non-motor Symptoms in Parkinson's Disease

Checks two new rating scales that measure non-motor symptoms in people with Parkinson's disease.

Plain-language title generated from the registry record
Registry title: International Validation of Two Non-motor Scales in PD (NFS and SPARK)

Key facts

Where
Bern, SwitzerlandSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 30 and 75 years old?

Source: NCT04366804, who can take part

Where in Switzerland

  • Insel Gruppe AG University Hospital BernBern, SwitzerlandNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Insel Gruppe AG, University Hospital Bern
Trial code
NCT04366804
Record updated
13 April 2025
Original description
The goal of this project is to develop the international validation of two new rating scales, the Neuropsychiatric Fluctuations Scale (NFS) and the Shame in PARKinson's disease (SPARK) Scale, in order to improve the understanding of the extent and severity of non-motor symptoms in Parkinson's disease (PD).Read full original descriptionShow less

International Validation of Two Non-motor Scales in Parkinson's Disease: the Neuropsychiatric Fluctuations Scale (NFS) and the Shame in Parkinson's Disease (SPARK) Scale

The goal of this project is to develop the international validation of two new rating scales, the Neuropsychiatric Fluctuations Scale (NFS) and the Shame in PARKinson's disease (SPARK) Scale, in order to improve the understanding of the extent and severity of non-motor symptoms in Parkinson's disease (PD).

Inclusion: Written informed consent; PD, according to the MDS criteria; Age of participants > 30 and < 75 years; Being fluent in the language in which the scales are applied.

Exclusion: Presence of PD dementia (defined as MoCA score < 24).

ClinicalTrials.gov NCT04366804